Ulla T Schultheiss1,2, Natalie Daya3, Morgan E Grams3,4, Jochen Seufert5, Michael Steffes6, Josef Coresh3, Elizabeth Selvin3, Anna Köttgen1,2,3. 1. Renal Division, Department of Medicine IV, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. 2. Division of Genetic Epidemiology, Institute of Medical Biometry and Statistics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 4. Division of Nephrology, Johns Hopkins University, Baltimore, MD, USA. 5. Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. 6. Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, USA.
Abstract
BACKGROUND: Reduced kidney function is a common public health problem that increases risk for a wide variety of adverse outcomes, making the identification of potentially modifiable factors associated with the development of incident chronic kidney disease (CKD) important. Alterations in the hypothalamic-pituitary-thyroid axis have been linked to reduced kidney function, but the association of thyroid function with the development of incident CKD is largely uncharacterized. METHODS: Concentrations of thyroid stimulating hormone (TSH), free thyroxine (FT4), triiodothyronine (T3) and thyroid peroxidase antibody (TPOAb) were quantified in 12 785 black and white participants of the ongoing community-based prospective Atherosclerosis Risk in Communities study. Thyroid markers and clinical categories of thyroid dysfunction (euthyroidism, combined subclinical and overt hypothyroidism, combined subclinical and overt hyperthyroidism) were also evaluated for their association with reduced kidney function (estimated glomerular filtration rate <60 mL/min/1.73 m2) at study baseline and with incident CKD over a median follow-up time of 19.6 years. RESULTS: Higher TSH and FT4 as well as lower T3 concentrations were strongly and independently associated with reduced kidney function at study baseline. The clinical entities hypothyroidism and hyperthyroidism were also associated with higher odds of baseline reduced kidney function, but this was not significant. However, none of the markers of thyroid function nor different clinical categories of thyroid dysfunction (hypothyroidism, hyperthyroidism or TPOAb positivity) were associated with incident CKD in adjusted analyses. CONCLUSIONS: Elevated TSH, FT4 and reduced T3 concentrations were associated with reduced kidney function cross-sectionally. The lack of association with the development of incident CKD suggests that altered thyroid function in the general population is not causally related to CKD development, but screening for thyroidal status may be especially relevant in persons with reduced kidney function.
BACKGROUND: Reduced kidney function is a common public health problem that increases risk for a wide variety of adverse outcomes, making the identification of potentially modifiable factors associated with the development of incident chronic kidney disease (CKD) important. Alterations in the hypothalamic-pituitary-thyroid axis have been linked to reduced kidney function, but the association of thyroid function with the development of incident CKD is largely uncharacterized. METHODS: Concentrations of thyroid stimulating hormone (TSH), free thyroxine (FT4), triiodothyronine (T3) and thyroid peroxidase antibody (TPOAb) were quantified in 12 785 black and white participants of the ongoing community-based prospective Atherosclerosis Risk in Communities study. Thyroid markers and clinical categories of thyroid dysfunction (euthyroidism, combined subclinical and overt hypothyroidism, combined subclinical and overt hyperthyroidism) were also evaluated for their association with reduced kidney function (estimated glomerular filtration rate <60 mL/min/1.73 m2) at study baseline and with incident CKD over a median follow-up time of 19.6 years. RESULTS: Higher TSH and FT4 as well as lower T3 concentrations were strongly and independently associated with reduced kidney function at study baseline. The clinical entities hypothyroidism and hyperthyroidism were also associated with higher odds of baseline reduced kidney function, but this was not significant. However, none of the markers of thyroid function nor different clinical categories of thyroid dysfunction (hypothyroidism, hyperthyroidism or TPOAb positivity) were associated with incident CKD in adjusted analyses. CONCLUSIONS: Elevated TSH, FT4 and reduced T3 concentrations were associated with reduced kidney function cross-sectionally. The lack of association with the development of incident CKD suggests that altered thyroid function in the general population is not causally related to CKD development, but screening for thyroidal status may be especially relevant in persons with reduced kidney function.
Authors: T Bjoro; J Holmen; O Krüger; K Midthjell; K Hunstad; T Schreiner; L Sandnes; H Brochmann Journal: Eur J Endocrinol Date: 2000-11 Impact factor: 6.664
Authors: Ulla T Schultheiss; Alexander Teumer; Marco Medici; Yong Li; Natalie Daya; Layal Chaker; Georg Homuth; Andre G Uitterlinden; Matthias Nauck; Albert Hofman; Elizabeth Selvin; Henry Völzke; Robin P Peeters; Anna Köttgen Journal: J Clin Endocrinol Metab Date: 2015-02-26 Impact factor: 5.958
Authors: F Monzani; N Caraccio; M Kozàkowà; A Dardano; F Vittone; A Virdis; S Taddei; C Palombo; E Ferrannini Journal: J Clin Endocrinol Metab Date: 2004-05 Impact factor: 5.958
Authors: Vania Cuna; Viola Menghi; Giorgia Comai; Maria Cappuccilli; Giuseppe Cianciolo; Concettina Raimondi; Francesco Grammatico; Gabriele Donati; Olga Baraldi; Irene Capelli; Gaetano LA Manna Journal: In Vivo Date: 2017 Nov-Dec Impact factor: 2.155
Authors: Nermin Diab; Natalie R Daya; Stephen P Juraschek; Seth S Martin; John W McEvoy; Ulla T Schultheiß; Anna Köttgen; Elizabeth Selvin Journal: Sci Rep Date: 2019-09-11 Impact factor: 4.379
Authors: Cheng-Wei Huang; Bonnie H Li; Kristi Reynolds; Steven J Jacobsen; Connie M Rhee; John J Sim Journal: Medicine (Baltimore) Date: 2020-04 Impact factor: 1.817
Authors: Ulla T Schultheiss; Inga Steinbrenner; Matthias Nauck; Markus P Schneider; Fruzsina Kotsis; Seema Baid-Agrawal; Elke Schaeffner; Kai-Uwe Eckardt; Anna Köttgen; Peggy Sekula Journal: Clin Kidney J Date: 2020-06-04